Company / R&D per Share
Tyra Biosciences, Inc. R&D per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.40
FY2024
5-year range
$1.03 / $4.67
FY2020-FY2024
Trend
-4.4%
vs FY2023
Sector context
#129 of 208
Health Care
What the data says
At $1.40, Tyra Biosciences, Inc.'s r&d per share ranks #129 of 208 in the Health Care sector. Improved from $1.03 to $1.40 over the past 2 years.
Based on SEC 10-K filings.
1.40 in FY2024 with a 3-year CAGR of -2.2%.
Improved from $1.03 to $1.40 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 208 in Health CareTop 62% of 208This company $1.40 Sector average $28.82
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 4.4% year-over-year.
- Ranks #129 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.40 | -4.4% |
| FY2023 | $1.46 | +42.6% |
| FY2022 | $1.03 | -31.4% |
| FY2021 | $1.50 | -67.9% |
| FY2020 | $4.67 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026